Larimar Therapeutics (LRMR) Shares Outstanding (Diluted) (2020 - 2025)
Larimar Therapeutics (LRMR) Shares Outstanding (Diluted) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,861.65 Bn | 66,861.36 Bn | - | 52.24 Mn |
| 2 | Nanobiotix | 1,910.87 Bn | 1,910.81 Bn | - | - |
| 3 | Akari Therapeutics | 989.71 Bn | 989.71 Bn | - | 118.76 Bn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 1.51 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 256.30 Mn |
| 6 | Regeneron Pharmaceuticals | 69.90 Bn | 61.14 Bn | 3.31 Bn | 107.70 Mn |
| 7 | Belite Bio | 62.74 Bn | 62.74 Bn | - | 680.00 |
| 8 | Argenx Se | 55.83 Bn | 50.65 Bn | 1.41 Bn | 64.41 Mn |
| 9 | Revolution Medicines | 37.46 Bn | 37.46 Bn | - | 198.10 Mn |
| 10 | Larimar Therapeutics | 36.62 Mn | -100.23 Mn | - | 78.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 78.32 Mn |
| Sep 30, 2025 | 78.32 Mn |
| Jun 30, 2025 | 64.03 Mn |
| Mar 31, 2025 | 63.96 Mn |
| Dec 31, 2024 | 61.26 Mn |
| Sep 30, 2024 | 63.81 Mn |
| Jun 30, 2024 | 63.80 Mn |
| Mar 31, 2024 | 53.55 Mn |
| Dec 31, 2023 | 43.90 Mn |
| Sep 30, 2023 | 43.90 Mn |
| Jun 30, 2023 | 43.90 Mn |
| Mar 31, 2023 | 43.90 Mn |
| Dec 31, 2022 | 25.76 Mn |
| Sep 30, 2022 | 22.23 Mn |
| Jun 30, 2022 | 18.34 Mn |
| Mar 31, 2022 | 18.34 Mn |
| Dec 31, 2021 | 17.16 Mn |
| Sep 30, 2021 | 18.29 Mn |
| Jun 30, 2021 | 16.00 Mn |
| Mar 31, 2021 | 16.00 Mn |